SIMPLE COMPOUNDS
Anxiolysis
Anxiolysis is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed
Magnitude: Not Assessed
I. Abstract
Non-proteinogenic amino acid found primarily in tea leaves, known for promoting relaxation without drowsiness.
Clinical Summary
Primary Efficacy
- — Partial seed from the compound directory for relaxation without drowsiness.
II. Activity Profile
Effects
documented physiological and clinical outcomes, ranked by evidence strength and magnitude
AnxiolysisSIMPLE COMPOUNDS
Anxiolysis is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed·Magnitude: Not Assessed
Sleep Quality ImprovementSIMPLE COMPOUNDS
Sleep Quality Improvement is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed·Magnitude: Not Assessed
Cognitive EnhancementSIMPLE COMPOUNDS
Cognitive Enhancement is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed·Magnitude: Not Assessed
SIMPLE COMPOUNDS
Sleep Quality Improvement
Sleep Quality Improvement is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed
Magnitude: Not Assessed
SIMPLE COMPOUNDS
Cognitive Enhancement
Cognitive Enhancement is indexed as a partial L-Theanine effect from the compound directory seed.
Evidence: Not Assessed
Magnitude: Not Assessed
III. Dose Evidence
Target Range
100mg - 200mg
Frequency
As needed
Timing
Day or evening
Clinical Notes
Partial protocol seed retained for generic monograph rendering proof.
VI. Key Studies
Curated source records that explain the evidence landscape for this compound, including endpoint evidence, mechanism anchors, dose context, safety context, and limiting evidence.
| Year | Literature | Evidence Role | Uses |
|---|---|---|---|
| 2019 | L-theanine in the adjunctive treatment of anxiety disorder Glass Label et al.·Journal of Clinical Psychiatry | direct endpoint evidence | 0 |